Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Aug. 10, 2020, 5:17 p.m. EDT

Inovio Pharma stock fluctuates after results, vaccine update

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Inovio Pharmaceuticals Inc. (INO)

or Cancel Already have a watchlist? Log In

By Wallace Witkowski

INO

Inovio Pharmaceuticals Inc. /zigman2/quotes/202993817/composite INO +7.14% shares fluctuated between slight gains and losses in the extended session Monday after the biotech company reported results that fell short of Wall Street estimates while it updated progress on its COVID-19 vaccine. Inovio shares were last up 0.6% after hours, following a 6.1% decline in the regular session to close at $18.99. For the year, shares are up 475%. The company reported a second-quarter loss of $128.7 million, or 83 cents a share, compared with a loss of $29.4 million, or 30 cents a share, in the year-ago period. Revenue rose to about $267,000 from about $136,000 in the year-ago quarter. Analysts surveyed by FactSet had forecast a loss of 17 cents a share on revenue of $2.6 million. The company said it expanded a 40-patient early-stage clinical trial by another 80 participants and that most patients were showing an immunological response to the vaccine. Inovio also said it received $71 million from the Department of Defense to support large-scale manufacturing of its Cellectra device that administered the vaccine.

/zigman2/quotes/202993817/composite
US : U.S.: Nasdaq
$ 18.21
+1.21 +7.14%
Volume: 7.00M
Sept. 21, 2020 9:59a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.85 billion
Rev. per Employee
$108,477
loading...

Get news alerts on Inovio Pharmaceuticals Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.